[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avalon Globocare (ALBT)

Avalon Globocare (ALBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avalon Globocare 4400 ROUTE 9 SOUTH SUITE 3100 FREEHOLD NJ 07728 USA

www.avalon-globocare.com Employees: 2 P: 732-780-4400 F: 732-780-5600

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Avalon GloboCare Corp. is a clinical-stage biotechnology company. It involved in developing and delivering innovative, transformative cellular therapeutics, precision diagnostics and clinical laboratory services. Avalon GloboCare Corp. is based in FREEHOLD, N.J.

Key Statistics

Overview:

Market Capitalization, $K 3,329
Enterprise Value, $K 34,659
Shares Outstanding, K 8,324
Float, K 6,310
% Float 75.81%
Short Interest, K 927
Short Float 11.14%
Days to Cover 1.00
Short Volume Ratio 0.20
% of Insider Shareholders 24.19%
% of Institutional Shareholders 1.42%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -18,260 K
Last Quarter Sales, $ 350 K
Last Quarter Net Income, $ -250 K
EBIT, $ -7,090 K
EBITDA, $ -5,790 K

Growth:

1-Year Return -89.33%
3-Year Return -98.51%
5-Year Return -99.74%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 77.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/14/25
Next Earnings Date 05/12/26 [--]
Earnings Per Share ttm -3.51
EPS Growth vs. Prev Qtr 97.03%
EPS Growth vs. Prev Year 96.70%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 10/28/24

ALBT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -64.78%
Profit Margin % 0.00%
Debt/Equity -1.01
Price/Sales 2.38
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.17
Interest Coverage -11.00
60-Month Beta -0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.